Sirio Pharma Co., Ltd. (SHE:300791)
24.45
+0.08 (0.33%)
Sep 5, 2025, 3:04 PM CST
Sirio Pharma Revenue
Sirio Pharma had revenue of 1.09B CNY in the quarter ending June 30, 2025, with 4.66% growth. This brings the company's revenue in the last twelve months to 4.26B, up 5.82% year-over-year. In the year 2024, Sirio Pharma had annual revenue of 4.21B with 17.56% growth.
Revenue (ttm)
4.26B
Revenue Growth
+5.82%
P/S Ratio
1.75
Revenue / Employee
1.54M
Employees
2,776
Market Cap
7.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.21B | 629.04M | 17.56% |
Dec 31, 2023 | 3.58B | 1.07B | 42.87% |
Jan 1, 2023 | 2.51B | 138.31M | 5.84% |
Dec 31, 2021 | 2.37B | 302.13M | 14.62% |
Dec 31, 2020 | 2.07B | 487.26M | 30.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Kweichow Moutai | 178.36B |
Wuliangye Yibin | 91.30B |
Muyuan Foods | 157.54B |
Shanxi Xinghuacun Fen Wine Factory | 37.23B |
Foshan Haitian Flavouring and Food Company | 27.97B |
Luzhou Laojiao Co.,Ltd | 30.75B |
Yihai Kerry Arawana Holdings | 245.07B |
Inner Mongolia Yili Industrial Group | 117.80B |